PLN-74809
PLN-74809-PSC-203
Phase 2 small_molecule completed
Quick answer
PLN-74809 for Primary Sclerosing Cholangitis is a Phase 2 program (small_molecule) at PLIANT THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PLIANT THERAPEUTICS, INC.
- Indication
- Primary Sclerosing Cholangitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed